CompletedPhase 3

Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

NCT00357994

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Site Reference ID/Investigator# 45719

Los Angeles, California, United States

+14 additional locations

Save this trial

Site Reference ID/Investigator# 45719Los Angeles, California, United States
Site Reference ID/Investigator# 45718Englewood, Colorado, United States
Site Reference ID/Investigator# 45722Washington D.C., District of Columbia, United States
Site Reference ID/Investigator# 45721Bradenton, Florida, United States
Site Reference ID/Investigator# 45705Gainesville, Florida, United States
Site Reference ID/Investigator# 45740Baltimore, Maryland, United States
Site Reference ID/Investigator# 45739St Louis, Missouri, United States
Site Reference ID/Investigator# 45703Burlington, Vermont, United States
Site Reference ID/Investigator# 44970Bochum, Germany
Site Reference ID/Investigator# 44971Bremerhaven, Germany
Site Reference ID/Investigator# 44973Dresden, Germany
Site Reference ID/Investigator# 44965Hanover, Germany
Site Reference ID/Investigator# 44964Kiel, Germany
Site Reference ID/Investigator# 44966Marburg, Germany
Site Reference ID/Investigator# 44968Tübingen, Germany